Peripheral Nerve Stimulators

Peripheral Nerve Stimulators

Global Peripheral Nerve Stimulators Market to Reach US$882.7 Million by 2030

The global market for Peripheral Nerve Stimulators estimated at US$659.6 Million in the year 2023, is expected to reach US$882.7 Million by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. Implantable Stimulators, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$497.0 Million by the end of the analysis period. Growth in the External Stimulators segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$179.7 Million While China is Forecast to Grow at 7.1% CAGR

The Peripheral Nerve Stimulators market in the U.S. is estimated at US$179.7 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$179.5 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Peripheral Nerve Stimulators Market - Key Trends & Drivers Summarized

Why Are Peripheral Nerve Stimulators Important in Pain Management and Neurological Treatment?

Peripheral nerve stimulators (PNS) are playing a crucial role in the management of chronic pain and neurological disorders. These devices are designed to deliver electrical impulses to peripheral nerves, effectively reducing pain signals sent to the brain. PNS devices are particularly beneficial for patients suffering from chronic pain conditions such as neuropathy, sciatica, or complex regional pain syndrome (CRPS), where traditional treatments like medications or physical therapy may be ineffective. Additionally, peripheral nerve stimulators are increasingly being used in the treatment of motor disorders and post-surgical pain management, offering a non-invasive and targeted approach to pain relief and functional recovery.

How Are Technological Advancements Revolutionizing Peripheral Nerve Stimulators?

Technological advancements in PNS devices are significantly enhancing their effectiveness, convenience, and accessibility. Modern stimulators are becoming more compact, wireless, and easier to implant, making the procedure less invasive for patients. Rechargeable and long-lasting battery systems are improving the convenience of these devices, allowing for extended periods of use without frequent maintenance. Innovations in bioelectronics, including closed-loop systems that automatically adjust stimulation based on the patient’s nerve activity, are optimizing pain relief while minimizing side effects. Furthermore, the integration of smartphone apps and wireless communication allows patients and healthcare providers to remotely monitor and adjust stimulation settings, offering personalized and adaptive treatment options.

What Regulatory Standards Govern Peripheral Nerve Stimulators?

Regulatory standards play a critical role in ensuring the safety and efficacy of peripheral nerve stimulators. In the U.S., the FDA regulates these devices as part of its broader oversight of medical devices, requiring clinical trials to demonstrate safety and effectiveness before market approval. In Europe, CE marking is required to ensure compliance with health and safety standards. Post-market surveillance is also crucial, as manufacturers are required to monitor the long-term performance and safety of PNS devices. These regulatory frameworks are designed to ensure that patients receive reliable and effective treatments while mitigating risks associated with device implantation and usage.

What Factors Are Driving the Growth of the Peripheral Nerve Stimulators Market?

The growth in the peripheral nerve stimulators market is driven by several factors, including the increasing prevalence of chronic pain conditions, technological advancements in neurostimulation devices, and growing awareness of non-invasive pain management solutions. As the incidence of chronic pain rises globally, more patients are seeking alternative treatments to manage pain without relying on opioids or invasive surgeries. Technological innovations, such as wireless, minimally invasive PNS devices, are making these treatments more accessible and effective, improving patient outcomes. Additionally, the expansion of healthcare infrastructure in emerging markets is providing new opportunities for PNS adoption, further driving market growth.

Select Competitors (Total 48 Featured) -

• Abbott Laboratories, Inc.
• Aleva Neurotherapeutics SA
• Avanos Medical, Inc.
• B. Braun SE
• Bioventus LLC
• Boston Scientific Corporation
• LivaNova PLC
• Medtronic, Inc.
• Neuronetics, Inc.
• NeuroSigma, Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.